临床试验

Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer

NCT：NCT05889390 · ACTIVE_NOT_RECRUITING

NCT编号NCT05889390

状态ACTIVE_NOT_RECRUITING

开始日期2023-02-20

完成时间2026-12-31

SponsorSemmelweis University (OTHER)

First posted2023-06-05

Last updated2026-05-15

简要摘要

The aim of this study is to investigate whether the application of concomitant modulated electro-hyperthermia in a neoadjuvant chemotherapeutic setting is beneficial for patients with HER2-negative, stage II-III breast cancer.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。